May 21, 2026
The Life and Legacy of Dr. Juliet Daniel: A Pioneer in Cancer Research and Champion of Health Equity the-life-and-legacy-of-dr-juliet-daniel-a-pioneer-in-cancer-research-and-champion-of-health-equity

The Life and Legacy of Dr. Juliet Daniel: A Pioneer in Cancer Research and Champion of Health Equity

Ammar Sabilarrohman September 11, 2025 0
The scientific community, McMaster University, and the global network of cancer researchers are mourning the profound loss...
Read More Read more about The Life and Legacy of Dr. Juliet Daniel: A Pioneer in Cancer Research and Champion of Health Equity
Strategic Expansion: Angelini Pharma to Acquire Catalyst Pharmaceuticals in $4.1 Billion Neuroscience Powerplay strategic-expansion-angelini-pharma-to-acquire-catalyst-pharmaceuticals-in-4-1-billion-neuroscience-powerplay

Strategic Expansion: Angelini Pharma to Acquire Catalyst Pharmaceuticals in $4.1 Billion Neuroscience Powerplay

Nila Kartika Wati September 9, 2025 0
By Gwendolyn Wu Published May 7, 2026 In a move that signals a significant shift in the...
Read More Read more about Strategic Expansion: Angelini Pharma to Acquire Catalyst Pharmaceuticals in $4.1 Billion Neuroscience Powerplay
Moderna’s mRNA Flu Vaccine Shows Superior Efficacy, Navigates FDA Review After Initial Hesitation modernas-mrna-flu-vaccine-shows-superior-efficacy-navigates-fda-review-after-initial-hesitation

Moderna’s mRNA Flu Vaccine Shows Superior Efficacy, Navigates FDA Review After Initial Hesitation

Ammar Sabilarrohman August 13, 2025 0
A groundbreaking Phase III trial has demonstrated that Moderna’s experimental mRNA-based flu vaccine, mRNA-1010, significantly outperforms a...
Read More Read more about Moderna’s mRNA Flu Vaccine Shows Superior Efficacy, Navigates FDA Review After Initial Hesitation
Japan Faces Uphill Battle to Achieve Lung Cancer Screening Goals Amidst Persistent Regional and Gender Disparities japan-faces-uphill-battle-to-achieve-lung-cancer-screening-goals-amidst-persistent-regional-and-gender-disparities

Japan Faces Uphill Battle to Achieve Lung Cancer Screening Goals Amidst Persistent Regional and Gender Disparities

Raul Delapena Setiawan August 13, 2025 0
Tokyo, Japan – May 7, 2026 – Japan’s ambitious national target of achieving 60% lung cancer screening...
Read More Read more about Japan Faces Uphill Battle to Achieve Lung Cancer Screening Goals Amidst Persistent Regional and Gender Disparities
Funding at a Crossroads: METAvivor Outlines High Stakes in FY 2027 Budget Battle and CDC Leadership Transition funding-at-a-crossroads-metavivor-outlines-high-stakes-in-fy-2027-budget-battle-and-cdc-leadership-transition

Funding at a Crossroads: METAvivor Outlines High Stakes in FY 2027 Budget Battle and CDC Leadership Transition

Nana Muazin August 11, 2025 0
WASHINGTON, D.C. — As the cherry blossoms reached their peak in the nation’s capital this April, the...
Read More Read more about Funding at a Crossroads: METAvivor Outlines High Stakes in FY 2027 Budget Battle and CDC Leadership Transition

You may have missed

decoding-the-future-how-the-broad-institute-is-revolutionizing-global-medicine

Decoding the Future: How the Broad Institute is Revolutionizing Global Medicine

Raul Delapena Setiawan May 21, 2026 0
its-not-over-yet-but-aerify-2s-disappointing-results-cast-a-shadow-over-its-epekimabs-copd-prospects

It’s Not Over Yet, But AERIFY-2’s Disappointing Results Cast a Shadow Over It’s Epekimab’s COPD Prospects

Sagoh May 21, 2026 0
a-new-frontier-in-pulmonary-care-oorja-bio-emerges-with-30m-to-tackle-lung-fibrosis

A New Frontier in Pulmonary Care: Oorja Bio Emerges with $30M to Tackle Lung Fibrosis

Evan Lee Salim May 21, 2026 0
new-research-links-glp-1-agonists-to-improved-breast-cancer-survival-rates

New Research Links GLP-1 Agonists to Improved Breast Cancer Survival Rates

Jia Lissa May 21, 2026 0